Glycomic Therapeutics Market Size And Share

  • Report Code : TIPRE00029576
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 330
Buy Now

Glycomic Therapeutics Market Size, Share, and Growth 2022-2028

Buy Now

Glycomic Therapeutics Market Report Glycomic Therapeutics Market Scope and Analysis Glycomic Therapeutics Market Size and Share

Glycomic Therapeutics Market: Strategic Insights

Glycomic Therapeutics Market

  • CAGR (2021 - 2028)
    15.8%
  • Market Size 2021
    US$ 99.02 Billion
  • Market Size 2028
    US$ 257.58 Billion

Market Dynamics

GROWTH DRIVERS
  • Increasing research in glycomics
  • Rising demand for personalized medicine
  • Technological advancements in glycan analysis
FUTURE TRENDS
  • Focus on glycan biomarker discovery
  • Advancements in glycosylation research
  • Integration with gene therapies
OPPORTUNITIES
  • Expanding application in cancer treatments
  • Growth in precision medicine market
  • Development of glycan-based therapeutics

Key Players

  • Intellihep Ltd
  • Protalix Biotherapeutics
  • BioMarin Pharmaceutical Inc
  • Genzyme Corporation Sanofi
  • Halozyme Therapeutics Inc
  • Bayer AG
  • Alzheon Inc
  • GlycoMar
  • GlaxoSmithKline plc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Class
  • Isolated and Synthetic
Structures
  • Glycoproteins
  • Targeting Sialic Acid
  • Proteoglycans
  • Targeting Glycosaminoglycans
  • Glycosylphosphatidylinositol-Anchored Proteins & Heparin Based Glycans
  • Targeting Glycosphingolipids
Indications
  • Thrombosis & Chemoprophylaxis
  • Anaemia
  • Anti-Adhesive & Anti-Inflammatory
  • Cataracts
  • Gaucher
Mode of Action
  • Inhibits Neuraminidase
  • Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate
  • Erythropoietin & Enzyme Replacement Therapy